OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
February 02, 2023
Improvement in viral vector yield has become integral to new cell and gene therapy product development.
September 16, 2022
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
September 01, 2022
Scaling up chromatography resins requires a thorough understanding of their intended use.
August 02, 2022
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
April 02, 2022
The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.
November 23, 2021
Takeda has exercised an option to co-develop and co-commercialize an investigational, brain-penetrant progranulin replacement therapy for the potential treatment of frontotemporal dementia-granulin.
September 01, 2021
Mechanistic models provide process understanding for developing robust manufacturing processes and for scale up and tech transfer.
August 19, 2021
Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.
August 09, 2021
AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.
July 21, 2021
Cellares has entered into a strategic relationship with Poseida Therapeutics to advance a closed, automated, and scalable cell therapy manufacturing system.